Dr. Nicolas A. Muruve, MD

Dr. Muruve practices at Cleveland Clinic Florida - Weston in Weston, Florida.

Dr. Muruve's NPI, 1700813078, was assigned on June 26, 2006. Dr. Muruve graduated from University of Manitoba in 1988. Dr. Muruve holds Florida license ME0087719.

Dr. Muruve's primary practice is Cleveland Clinic Florida - Weston, at 2950 Cleveland Clinic Blvd, Weston, FL 33331 in Broward County. The practice phone is (954) 689-5000.

Dr. Muruve's primary practice is Cleveland Clinic Florida - Weston in Weston, Florida. Dr. Muruve is also affiliated with Cleveland Clinic Weston Hospital. The medical group on file is Cleveland Clinic Florida. Dmand AI also links Dr. Muruve to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Muruve practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Muruve's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Muruve is board certified in urology by the American Board of Urology. Dmand AI has Dr. Muruve's licenses on file in 3 states: Florida, Missouri and Ohio.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease, prostate cancer and urinary endoscopy among the conditions Dr. Muruve treats.

CMS data shows 696 Medicare services from Dr. Muruve across 8 procedure codes in 2024, for 432 Medicare patients. Medicare paid $44,190 for them.

CMS counts 432 Medicare patients who saw Dr. Muruve in 2024. The largest group is 65 to 74, with 189 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Muruve's median patient age at 69, with 27% women.

In 2024, Dr. Muruve wrote 674 Medicare Part D claims for 257 patients. 87% of them were for generic drugs. CMS names the drug for 585 of them, across 11 drugs with 11 or more claims each, at $764,144 in total drug cost. In 2023, CMS named 638 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Muruve for performance year 2024, reported through an alternative payment model (APM). Dr. Muruve accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Muruve as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Muruve, published from 2014 to 2019. 2014 was the busiest year, with 2. The most frequent topics are Kidney Transplantation, Cadaver and Histocompatibility Testing. Dr. Muruve has published most often in Clin Transplant. Dr. Muruve's most frequent co-authors are John W. Berkenbosch, MD, Robert Leo Fairchild, MD and Vishnuvardhan Ganesan.

CMS Open Payments shows 289 general payments to Dr. Muruve from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,471.

Dmand AI lists 3 awards for Dr. Muruve, most recently Regional Top Doctor in 2014.

Dr. Muruve graduated from University of Manitoba in 1988.

Dr. Muruve is in network with 13 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.